A detailed history of Israel Englander (Millennium Management LLC) transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,963,181 shares of VERV stock, worth $29.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,963,181
Previous 100,000 4863.18%
Holding current value
$29.3 Million
Previous $488,000 4822.34%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.4 - $7.86 $4.81 Million - $8.59 Million
1,092,341 Added 28.22%
4,963,181 $24 Million
Q2 2024

Aug 14, 2024

BUY
$4.76 - $12.79 $15.5 Million - $41.6 Million
3,256,410 Added 529.99%
3,870,840 $18.9 Million
Q1 2024

May 15, 2024

BUY
$10.81 - $17.96 $6.64 Million - $11 Million
614,430 New
614,430 $8.16 Million
Q1 2023

May 15, 2023

BUY
$14.3 - $24.01 $410,109 - $688,582
28,679 New
28,679 $414,000

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $354M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.